Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

2.

Participation of adolescents with cancer in clinical trials.

Ferrari A, Bleyer A.

Cancer Treat Rev. 2007 Nov;33(7):603-8. Epub 2007 Jan 23. Review.

PMID:
17250970
3.
4.
6.

Clinical trial enrollment among adolescents with cancer: supplement overview.

Tai E, Beaupin L, Bleyer A.

Pediatrics. 2014 Jun;133 Suppl 3:S85-90. doi: 10.1542/peds.2014-0122B. Review.

7.

Challenges in the recruitment of adolescents and young adults to cancer clinical trials.

Burke ME, Albritton K, Marina N.

Cancer. 2007 Dec 1;110(11):2385-93. Review.

8.

The challenges of clinical trials for adolescents and young adults with cancer.

Ferrari A, Montello M, Budd T, Bleyer A.

Pediatr Blood Cancer. 2008 May;50(5 Suppl):1101-4. doi: 10.1002/pbc.21459. Review.

PMID:
18360838
9.

Treatment setting, clinical trial enrollment, and subsequent outcomes among adolescents with cancer: a literature review.

Tai E, Buchanan N, Westervelt L, Elimam D, Lawvere S.

Pediatrics. 2014 Jun;133 Suppl 3:S91-7. doi: 10.1542/peds.2014-0122C. Review.

10.

The management of cancer in the older adolescent.

Albritton K, Bleyer WA.

Eur J Cancer. 2003 Dec;39(18):2584-99. Review.

PMID:
14642921
11.
12.

Improving enrollment in clinical trials for adolescents with cancer.

Shaw PH, Hayes-Lattin B, Johnson R, Bleyer A.

Pediatrics. 2014 Jun;133 Suppl 3:S109-13. doi: 10.1542/peds.2014-0122F. Review.

13.

Fetal and neonatal hepatic tumors.

Isaacs H Jr.

J Pediatr Surg. 2007 Nov;42(11):1797-803. Review.

PMID:
18022426
14.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
15.

Survival from adolescent cancer.

Desandes E.

Cancer Treat Rev. 2007 Nov;33(7):609-15. Epub 2007 Mar 29. Review.

PMID:
17398011
16.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
17.

Understanding and addressing the lack of clinical trial enrollment among adolescents with cancer.

Tai E, Buchanan N, Eliman D, Westervelt L, Beaupin L, Lawvere S, Bleyer A.

Pediatrics. 2014 Jun;133 Suppl 3:S98-S103. doi: 10.1542/peds.2014-0122D. Review.

18.

Influencing referral of adolescents and young adults with cancer to sites with higher rates of trial enrollment.

Albritton KH, Coccia P.

Pediatrics. 2014 Jun;133 Suppl 3:S104-8. doi: 10.1542/peds.2014-0122E. Review.

19.

Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials.

Fern LA, Lewandowski JA, Coxon KM, Whelan J; National Cancer Research Institute Teenage and Young Adult Clinical Studies Group, UK..

Lancet Oncol. 2014 Jul;15(8):e341-50. doi: 10.1016/S1470-2045(14)70113-5. Review.

PMID:
24988937
20.

Adolescent and Young Adult (AYA) Oncology in the United States: A Specialty in Its Late Adolescence.

Shaw PH, Reed DR, Yeager N, Zebrack B, Castellino SM, Bleyer A.

J Pediatr Hematol Oncol. 2015 Apr;37(3):161-9. doi: 10.1097/MPH.0000000000000318. Review.

PMID:
25757020

Supplemental Content

Support Center